Clinical trial
Factors That Influence Compliance With Disease-Modifying Therapy in Multiple…
NCT00223457 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00223457 |
|---|---|
| Title | Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis |
| Official title | Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | Biogen Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Intervention type | Behavioral |
| Interventions | Factors that influence compliance |
| Enrollment | 1,040 |
| Start date | Apr 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: